Clinical Trial Update: Study of BEMA™ Fentanyl in the Treatment of Breakthrough Pain in Cancer Subjects [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for BEMA fentanyl in treating breakthrough pain in cancer patients; results have been posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Pain

Drugs mentioned

• BEMA Fentanyl (fentanyl)

Snippet

Sponsor: BioDelivery Sciences International | Conditions: Pain, Cancer | Phase 3 | Status: COMPLETED | Results posted: 2019-10-21